Eric P Hoffman

17PUBLICATIONS
70CO-AUTHORS
Predictive and prognostic markersMedical virologyMolecular medicinePharmacogenomicsMotor control
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Aug 19, 2026
Integrating Genetic Modifier Genotype With Serum Proteomics in Duchenne Muscular Dystrophy Clinical Trials Links LTBP4 Genetic Modifier to IL-23/CD93 Pathways in Muscle.

|May 27, 2026
Vamorolone for Duchenne Muscular Dystrophy: A Cross-Trial Efficacy Comparison With Classic Corticosteroids From the FOR-DMD Trial.

|May 15, 2026
Vamorolone Safety, Pharmacokinetics, and Exploratory Efficacy in Duchenne Muscular Dystrophy: A Phase II, Nonrandomized, Multiple-Dose Study in 2-<4-Year-Old Boys.

|Mar 03, 2026
Results of a phase II open-label, multiple-dose study of vamorolone (VBP15-006) in 7- to < 18-year-old boys with duchenne muscular dystrophy.

Hanns Lochmüller, Hernan Gonorazky, Elisa Nigro

|Sep 03, 2025
Test-Retest Reliability of Motor Function and Myometry Outcomes From the Vamorolone Trials in Duchenne Muscular Dystrophy.

Rebecca A Tobin, Eric P Hoffman, Linda Johnson

|Feb 28, 2025
Association of DMD Gene Variant Classes With Motor Outcomes in a Drug Registration Clinical Trial Setting.

Yuan Fang, Utkarsh J Dang, Katherine I Illei

Pageof 3

Frequent Collaborators

4 joint publications

Michela Guglieri

4 joint publications

Paula R Clemens

4 joint publications

Utkarsh J Dang

3 joint publications

Jean K Mah